Medulloblastoma: Histopathologic and molecular markers of anaplasia and biologic behavior

Acta Neuropathologica

Volumn 112, Issue 1, 2006, Pages 13-20

  Min, Hye Sook ^a   Lee, You Jeong ^a   Park, Kyeongmee ^b   Cho, Byung Kyu ^a   Park, Sung Hye ^a  

^a Seoul National University   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Anaplasia; FISH; Large cell; Medulloblastoma; Prognosis

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; MEMBRANE PROTEIN; MOLECULAR MARKER; MYC PROTEIN; PROTEIN NEUN; PROTEIN P53; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; METASTASIS; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID AMPLIFICATION; ONCOGENE C MYB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REPRODUCIBILITY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADOLESCENT; AGE FACTORS; ANAPLASIA; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MEDULLOBLASTOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 33745389589     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-006-0073-9     Document Type: Article

References (31)

1. Aldosari N, Bigner SH, Burger PC, Becker L, Kepner JL, Friedman HS, McLendon RE (2002) MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. Arch Pathol Lab Med 126:540-4
2. Batra SK, McLendon RE, Koo JS, Castelino-Prabhu S, Fuchs HE, Krischer JP, Friedman HS, Bigner DD, Bigner SH (1995) Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neurooncol 24:39-45
3. Brown HG, Kepner JL, Perlman EJ, Friedman HS, Strother DR, Duffner PK, Kun LE, Goldthwaite PT, Burger PC (2000) "Large cell/ anaplastic" medulloblastomas: A Pediatric Oncology Group Study. J Neuropathol Exp Neurol 59:857-65
4. Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93:1351-1359
5. DeChiara C, Borghese A, Fiorillo A, Genesio R, Conti A, D'Amore R, Pettinato G, Varone A, Maggi G (2002) Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality. Childs Nerv Syst 18:380-4
6. Eberhart CG, Burger PC (2003) Anaplasia and grading in medulloblastomas. Brain Pathol 13:376-85
7. Eberhart CG, Chaudhry A, Daniel RW, Khaki L, Shah KV, Gravitt PE (2005) Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus. BMC Cancer 5:19
8. Eberhart CG, Kepner JL, Goldthwaite PT, Kun LE, Duffner PK, Friedman HS, Strother DR, Burger PC (2002) Histopathologic grading of medulloblastomas: A Pediatric Oncology Group study. Cancer 94:552-60
9. Ellison DW (2002) Classifying the medulloblastoma: Insights from morphology and molecular genetics. Neuropathol Appl Neurobiol 28:257-282
10. Fan X, Wang Y, Kratz J, Brat DJ, Robitaille Y, Moghrabi A, Perlman EJ, Dang CV, Burger PC, Eberhart CG (2003) hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors. Am J Pathol 162:1763-9
11. Fisher PG, Burger PC, Eberhart CG (2004) Biologic risk stratification of medulloblastoma: The real time is now. J Clin Oncol 22:971-4
12. Frank AJ, Hernan R, Hollander A, Lindsey JC, Lusher ME, Fuller CE, Clifford SC, Gilbertson RJ (2004) The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma. Brain Res Mol Brain Res 121:137-40
13. Gajjar A, Hernan R, Kocak M, Fuller C, Lee Y, McKinnon PJ, Wallace D, Lau C, Chintagumpala M, Ashley DM, Kellie SJ, Kun L (2004) Clinical, histopathologic, and molecular markers of prognosis: Toward a new disease risk stratification system for medulloblastoma. J Clin Oncol 22:984-93
14. Giangaspero F, Bigner SH, Kleihues P, Pietsch T, Trojanowski JQ 2000 Meulloblastoma. In: Kleihues P, Cavenee WK (eds) World Health Organization classification of tumours: Pathology, genetic of tumours of the nervous system, International Agency for Research on Cancer, Lyon, pp 129-137
15. Giangaspero F, Rigobello L, Badiali M, Loda M, Andreini L, Basso G, Zorzi F, Montaldi A (1992) Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol 16:687-93
16. Gilbertson R, Wickramasinghe C, Hernan R, Balaji V, Hunt D, Jones-Wallace D, Crolla J, Perry R, Lunec J, Pearson AD, Ellison DW (2001) Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer 85:705-12
17. Gilbertson RJ, Clifford SC (2003) PDGFRB is overexpressed in metastatic medulloblastoma. Nat Genet 35:197-8
18. Giordana MT, D'Agostino C, Pollo B, Silvani A, Ferracini R, Paiolo A, Ghiglione P, Chio A (2005) Anaplasia is rare and does not influence prognosis in adult medulloblastoma. J Neuropathol Exp Neurol 64:869-874
19. Grotzer MA, Janss AJ, Fung K, Biegel JA, Sutton LN, Rorke LB, Zhao H, Cnaan A, Phillips PC, Lee VM, Trojanowski JQ (2000) TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol 18:1027-35
20. Herms J, Neidt I, Luscher B, Sommer A, Schurmann P, Schroder T, Bergmann M, Wilken B, Probst-Cousin S, Hernaiz-Driever P, Behnke J, Hanefeld F, Pietsch T, Kretzschmar HA (2000) C-MYC expression in medulloblastoma and its prognostic value. Int J Cancer 89:395-402
21. Herms JW, Behnke J, Bergmann M, Christen HJ, Kolb R, Wilkening M, Markakis E, Hanefeld F, Kretzschmar HA (1997) Potential prognostic value of C-erbB-2 expression in medulloblastomas in very young children. J Pediatr Hematol Oncol 19:510-5
22. Kopelson G, Linggood RM, Kleinman GM (1983) Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management. Cancer 51:312-9
23. Lamont JM, McManamy CS, Pearson AD, Clifford SC, Ellison DW (2004) Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. Clin Cancer Res 10:5482-93
24. McManamy CS, Lamont JM, Taylor RE, Cole M, Pearson A, Clifford SC, Ellison DW (2003) Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas. J Neuropathol Exp Neurol 62:627-32
25. Miralbell R, Tolnay M, Bieri S, Probst A, Sappino AP, Berchtold W, Pepper MS, Pizzolato G (1999) Pediatric medulloblastoma: Prognostic value of p53, bcl-2, Mib-1, and microvessel density. J Neurooncol 45:103-10
26. Neben K, Korshunov A, Benner A, Wrobel G, Hahn M, Kokocinski F, Golanov A, Joos S, Lichter P (2004) Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res 64:3103-3111
27. Ozer E, Sarialioglu F, Cetingoz R, Yuceer N, Cakmakci H, Ozkal S, Olgan N, Uysal K, Corapcioglu F, Canda S (2004) Prognostic significance of anaplasia and angiogenesis in childhood medulloblastoma: A pediatric oncology group study. Pathol Res Pract 200:501-509
28. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-42
29. Sarkar C, Pramanik P, Karak AK, Mukhopadhyay P, Sharma MC, Singh VP, Mehta VS (2002) Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index. J Neurooncol 59:49-61
30. Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL (1994) Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91:12867-71
31. Urberuaga A, Navajas A, Burgos J, Pijoan JI (2005) A review of clinical and histoloical features of Spanish paediatric medulloblastomas during the last 21 years. Child Nerv Syst 9:1-9